English   español  

Browsing by Author Palomo, Valle

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg28-Jun-20163,4-dihydroxyphenylalanine peptides as non-perturbative quantum dot sensors of aminopeptidasePalomo, Valle ; Díaz, Sebastián A.; Stewart, Michael H.; Susumu, Kimihiro; Medintz, Igor L.; Dawson, Philip E.artículo
openAccessEOID_Postprint_2017.pdf.jpgApr-2017Drugs on clinical development for the treatment of amyotrophic lateral sclerosisMartínez, Ana ; Palomo, Valle ; Pérez, Daniel I.; Gil, Carmen  artículo
closedAccessaccesoRestringido.pdf.jpg31-Jul-2018Efficient assembly of quantum dots with homogenous glycans derived from natural N-linked glycoproteinsPalomo, Valle ; Cistrone, Philip A; Zhan, Naiqian; Palui, Goutam; Mattoussi, Hedi; Philip E. Dawsonartículo
openAccessExpert Opinion on Therapeutic Patents_palomo_2016.pdf.jpg21-Nov-2016Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)Palomo, Valle ; Martínez, Ana artículo
closedAccessaccesoRestringido.pdf.jpg2014Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X miceFranklin, Aimee V.; King, Margaret K.; Palomo, Valle ; Martínez, Ana ; McMahon Lori L.; Jope, Richard S.artículo
openAccessAnal. Real Acad. Nal. Farm._Nozal_ 2019.pdf.jpg2019Improved linkage design for the discovery of multitarget ligands as powerful drugs for Alzheimer’s diseaseNozal, V.; García-Rubia, Alfonso; Pérez, Concepción; Martínez, Ana ; Palomo, Valle artículo
openAccess13024_2018_Article_251.pdf.jpg16-Apr-2018Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosaSánchez-Cruz, Alonso; Villarejo-Zori, Beatriz; Marchena, Miguel; Zaldívar-Díez, Josefa; Palomo, Valle ; Gil, Carmen  ; Lizasoain, Ignacio; de la Villa, Pedro; Martínez, Ana ; De la Rosa, Enrique J. ; Hernández-Sánchez, Catalina artículo
openAccessCongreso Atenas p.110.pdf.jpgSep-2019Multitarget triazoles: an innovative approach for the treatment of Alzheimer’s diseaseNozal, V.; García-Rubia, Alfonso; Roca, Carlos; Pérez, Concepción; Palomo, Valle ; Martínez, Ana comunicación de congreso
openAccess2019Optimización de la estrategia de unión en el diseño de compuestos multidiana prometedores para el tratamiento de la enfermedad de AlzheimerNozal, V.; García-Rubia, Alfonso; Pérez, Concepción; Martínez, Ana ; Palomo, Valle artículo
closedAccessaccesoRestringido.pdf.jpg2013Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3Beurel, Eleonore; Kaidanovich-Beilin, Oksana; Yeh, Wen-I.; Song, Ling; Palomo, Valle ; Michalek, Suzane M.; Woodgett, James R.; Harrington, Laurie E.; Eldar-Finkelman, Hagit; Martínez, Ana ; Jope, Richard S.artículo
openAccessde Munck_journal.pone_2016.pdf.jpg15-Sep-2016Small GSK-3 inhibitor shows efficacy in a motor neuron disease murine model modulating autophagyDe Munck, E.; Palomo, Valle ; Muñoz-Sáez, E.; Pérez Fernández, Daniel Ignacio ; Gómez-Miguel, Begoña; Solas, M. Teresa; Gil, Carmen  ; Martínez, Ana ; Arahuetes, Rosa Mªartículo
openAccessJ.Enz. Inhibit. Med. Chem. 2017.pdf.jpg23-Jan-2017Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosaMarchena, Miguel; Villarejo-Zori, Beatriz; Zaldívar-Díez, Josefa; Palomo, Valle ; Gil, Carmen  ; Hernández-Sánchez, Catalina ; Martínez, Ana ; De la Rosa, Enrique J. artículo
openAccessacs-cn_revised_2019.pdf.jpg20-Mar-2019TDP-43: a key therapeutic target beyond amyotrophic lateral sclerosisPalomo, Valle ; Tosat-Bitrian, Carlota; Nozal, V.; Nagaraj, Siranjeevi; Martín-Requero, Ángeles ; Martínez, Ana artículo